Orexo enhances commercial focus and operating efficiencies

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 20, 2014 at 5:15 AM

Uppsala, Sweden – August 20, 2014 – Orexo AB (publ) announces today that the company is taking further steps to enhance commercial focus, agility and operating efficiency. The sales development of Zubsolv® continues to evolve positively with the tablet sales increasing 64% in volume the last four weeks compared to the last month of the second quarter. The market share has improved from 2.3% in June to 3.9% in the first week of August. This positive sales development is primarily driven by improvements in Zubsolv’s market access position and the exclusive contract with UnitedHealth Group in particular. The improvement in market access continues to progress well, and Orexo is pleased to announce that the largest commercial payer, the PBM Express Script (ESI), will place Zubsolv on their preferred formulary effective January 1, 2015. In addition, many public payers are improving the reimbursement of Zubsolv in several large states such as Michigan, Texas and California. With the improved market access, additional 991 physicians have prescribed Zubsolv for the first time after July 1 and market share has increased in several sales districts. The prescriptions of Zubsolv are on a four week basis growing double digit for patients in all payer segments, with exception of FFS Medicaid accounting for around 10% of the market. Within the commercial payer segment, the market share exceeds 5% in two thirds of the districts and 10% of new prescriptions in several sales districts. As a next step to improve operating efficiency, Orexo has taken the decision to place all manufacturing of Zubsolv at our partners in the US and streamline the operations in Uppsala. The facilities in Uppsala will focus on new product development, product maintenance and global external sourcing and supply, and continue as the global headquarter for Orexo AB. Additionally, Orexo is revisiting the operating model within research and development to increase flexibility and agility in development of new products and life cycle activities. These adjustments in Orexo’s operating model could result in approximately 15 positions being identified as redundant at the facilities in Uppsala, Sweden. The restructuring of the Swedish operations is expected to be completed during the fourth quarter of 2014 and will be associated with restructuring costs of approx. MSEK 7 during the same quarter and an annual cost saving of around MSEK 10-15, with a positive impact beginning already in the first quarter of 2015. “During the last year, Orexo has successfully established commercial operations in the US and the focus has been entirely on the launch of Zubsolv. We are pleased with the sales improvements during the summer and are excited about the continuing improvements in market access. Now it is time to ensure we have the optimal operating model for the future, with the appropriate focus and agility necessary to develop the next generation in the Zubsolv line and other new products. This new operating model will build more on external partnerships to ensure we complement our excellent and proven internal development team with leading international expertise. This important change increases Orexo’s ability to flex its resources within development more swiftly while enhancing our ability to develop new products” says Nikolaj Sørensen, CEO and President of Orexo AB. For further information, please contact: Nikolaj Sørensen, President and CEO Tel: +46 (0)703-50 78 88, E-mail: ir@orexo.com About Orexo AB Orexo is a specialty pharma company with commercial operations in the United States and R&D in Sweden developing improved treatments using proprietary drug delivery technology and commercial operations in the United States. The company is commercializing its proprietary product, ZUBSOLV® sublingual tablets, for maintenance treatment of opioid dependence, in the United States. The ZUBSOLV® sublingual tablet is a novel formulation of buprenorphine and naloxone using Orexo’s extensive knowledge in sublingual technologies. Orexo has a portfolio of two approved and revenue generating products currently marketed under license in the US, EU and Japan. Orexo AB, with its headquarters in Sweden, is listed on NASDAQ OMX Stockholm Exchange and its American Depositary Receipts (ADRs) trade on the OTCQX marketplace in the U.S. under the symbol, “ORXOY”. The largest shareholders are Novo A/S and HealthCap. For information about Orexo, please visit www.orexo.com. Orexo AB (publ) discloses the information provided herein pursuant to the Financial Instruments Trading Act and/or the Securities Markets Act. The information was submitted for publication at 11:00am CET on August 20, 2014.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HNTB Expands in Capital Region: A Strategic Move

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Annex Brands Grows with Bastrop's PostalAnnex Opening

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Nature-Based Solutions: The Economic And Community Impact

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Tenera Care's Tech Triumph: Halving Falls with Simplicity

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Molex's VersaBeam Mini Pushes AI Data Center Limits

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Lavior and CR Fitness Team for Wellness Reach

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Lawsuit Targets Electrical Consultants' Labor Practices

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Castillo Engineering Gears Up with New VP Appointments

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Lititz Mutual Embraces AI with Guidewire ProNavigator

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...